Literature DB >> 7150485

Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship.

S Rajaratnam, G E Adams, I J Stratford, C Clarke.   

Abstract

The cytotoxicity of 3 electron-affinic radiosensitizers has been studied in Chinese hamster V-79 cells as a function of pH and modest hyperthermia. When equitoxic concentrations were used and temperature was increased from 34 to 41 degrees C metronidazole, the compound with the lowest electron affinity showed the greatest enhancement of hypoxic-cell toxicity, and nitrofurantoin, the compound with the highest electron affinity, the least. The results can be explained if the mechanisms of toxicity involves a redox reaction, since it would be expected that the least toxic compound (lowest electron affinity) would have the largest activation energy and hence the greatest temperature effect. This appears to hold for these 3 compounds. Experiments also showed that nitrofurantoin which exhibits no increase in toxicity when the temperature was increased from 37 to 41 degrees C at pH 7.4, showed an increase in toxicity for the same temperature change at the pH of 7.0 and 6.6. Under aerobic conditions only metronidazole showed significant toxicity at 41 degrees C, where the differential between aerobic and hypoxic cell toxicity was minimal, both at pH 7.4, and at the low pH values of 7.0 and 6.6. In the clinical setting there is evidence that tumour cells are at a lower pH than their surrounding normal tissues. Hypoxic-cell cytotoxicity is enhanced at low pH, and even further enhanced at low pH in combination with a temperature of 41 degrees C. However, this finding correlates conversely with electron affinity. Thus, the radiosensitizer (and trichomonicide) metronidazole is most influenced by low pH and high temperature with the nitroimidazole, misonidazole, demonstrating a smaller enhancement due to higher temperatures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150485      PMCID: PMC2011234          DOI: 10.1038/bjc.1982.301

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Hypoxic sensitizers: radiobiological studies at the cellular level.

Authors:  E J Hall; L Roizin-Towle
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

2.  The pH of rat tumors measured in vivo.

Authors:  M EDEN; B HAINES; H KAHLER
Journal:  J Natl Cancer Inst       Date:  1955-10       Impact factor: 13.506

3.  Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.

Authors:  B A Moore; B Palcic; L D Skarsgard
Journal:  Radiat Res       Date:  1976-09       Impact factor: 2.841

Review 4.  Selective multiphase cancer therapy: conceptual aspects and experimental basis.

Authors:  M von Ardenne
Journal:  Adv Pharmacol Chemother       Date:  1972

5.  pH studies in human malignant tumours.

Authors:  B S Ashby
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

6.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

7.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

8.  Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells.

Authors:  I J Stratford; P Gray
Journal:  Br J Cancer Suppl       Date:  1978-06

9.  Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential.

Authors:  G E Adams; I J Stratford; R G Wallace; P Wardman; M E Watts
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

  9 in total
  3 in total

1.  Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; M Ohta; M Takahashi; K Kobayashi; S Kiuchi; K Okui; T Miyoshi; N Arimizu
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

2.  Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.

Authors:  T Kusumoto; Y Maehara; Y Emi; Y Sakaguchi; H Baba; M Sakaguchi; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.

Authors:  S Fujimoto; M Ohta; R D Shrestha; M Kokubun; T Miyoshi; T Mori; N Arimizu; K Okui
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.